FRANCE – Volta Medical, a Marseille, France-based health technology company developing artificial intelligence (AI) solutions, raised €63M in Series B funding.
The round, which brought bringing the total capital raised to over €70M, was led by Vensana Capital with participation from Lightstone Ventures and existing investor Gilde Healthcare. The company intends to use the funds to accelerate new product development, support additional clinical trials, prepare for full-scale US commercialization, and pursue further regulatory approvals. Led by CEO Theophile Mohr Durdez, Volta Medical is a health technology company developing artificial intelligence software solutions to assist cardiac electrophysiologists during arrhythmia treatment procedures to improve clinical outcomes for patients. Its first product, VX1, is a digital AI companion device and algorithm to assist cardiologists with real-time identification of specific abnormal electrograms (EGMs), known as dispersed EGMs. 05/01/2023
